75 results on '"Al-Kindi, Sadeer G."'
Search Results
2. Ambient Air Pollution and Mortality After Cardiac Transplantation.
3. Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.
4. NEIGHBORHOOD EXPOSOME, CORONARY ARTERY CALCIUM SCORE, AND CARDIOVASCULAR RISK: INSIGHTS FROM CLARIFY.
5. ASSOCIATION OF KETONE BODIES AND INCIDENT DIABETES IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA).
6. SATELLITE IMAGE-DERIVED NEIGHBORHOOD CHARACTERICS EXPLAIN REGIONAL VARIATION IN CARDIOMETABOLIC DISEASE.
7. HISTORICAL NEIGHBORHOOD REDLINING CONTINUES TO ADVERSELY INFLUENCE CARDIOVASCULAR OUTCOMES IN US VETERANS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.
8. DEPRESSION IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR DISEASE AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE.
9. PREVALENCE OF THORACIC AORTIC ANEURYSM IN PATIENTS REFERRED FOR NO-CHARGE CORONARY ARTERY CALCIUM SCORING: INSIGHTS FROM THE CLARIFY REGISTRY.
10. Climate Change, Environmental Pollution, and the Role of Cardiologists of the Future.
11. Reimagining Training in Cardiac CT for Cardiology Fellows.
12. Reply: Pollution and Organ Transplantation.
13. THE BENEFITS OF INTENSIVE VERSUS STANDARD BLOOD PRESSURE TREATMENT ACCORDING TO FINE PARTICULATE MATTER AIR POLLUTION EXPOSURE: A POST-HOC ANALYSIS OF SPRINT.
14. IMMUNO-HEMATOLOGIC DYSFUNCTION AS A NOVEL RISK FACTOR FOR CARDIOVASCULAR DISEASE AND MORTALITY.
15. CORONARY ARTERY CALCIUM SCORING AND OUTCOMES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA: INSIGHTS FROM CLARIFY.
16. IMPACT OF CORONARY ARTERY CALCIUM SCORING ON STATIN-ELIGIBILITY AND OUTCOMES IN WOMEN: THE CLARIFY STUDY.
17. Lack of Association Between Cardiac Index and Kidney Dysfunction: Validation in Patients Awaiting Heart Transplantation.
18. EVALUATION OF HIV-ASSOCIATED DYSPNEA USING CARDIAC MAGNETIC RESONANCE CARDIOPULMONARY EXERCISE TESTING (CMR-CPET).
19. IMPACT OF NO-COST CORONARY CALCIUM SCORE TESTING IN PATIENTS AT RISK FOR CARDIOVASCULAR DISEASE ON PATIENT REPRESENTATION AND DIAGNOSTIC YIELD.
20. AMBIENT AIR POLLUTION AND MORTALITY AFTER HEART TRANSPLANTATION.
21. REDUCTION IN CARDIOVASCULAR MORTALITY AMONG SURVIVORS OF CHILDHOOD LYMPHOID CANCERS IN THE UNITED STATES.
22. NATIONWIDE DIFFERENCES IN THE UTILIZATION OF MECHANICAL CIRCULATORY SUPPORT AS BRIDGE TO TRANSPLANTATION IN THE UNITED STATES.
23. HIGH RISK DONOR HEART TRANSPLANTATION IS NOT ASSOCIATED WITH WORSE GRAFT SURVIVAL.
24. TCTAP C-164 Cardiac MRI Sizing for Left Atrial Appendage Closure.
25. RISK STRATIFICATION OF POST-TAVR NEW LBBB OUTCOMES: INSIGHTS FROM A MULTICENTER INTERNATIONAL STUDY.
26. LONG-TERM OUTCOMES OF POST-TAVR TRANSIENT LEFT BUNDLE BRANCH BLOCK: INSIGHTS FROM A MULTICENTER INTERNATIONAL STUDY.
27. CORONARY ARTERY CALCIUM SCORING AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PROSTATE CANCER.
28. BLOOD PRESSURE-INDEPENDENT EFFECTS OF MINERALOCORTICOID RECEPTOR BLOCKADE.
29. VARIATION IN THE SERUM BIOMARKER LEVELS ACROSS WORSENING OBESITY CATEGORIES: MIAMI HEART STUDY AT BAPTIST HEALTH SOUTH FLORIDA.
30. FINE PARTICULATE MATTER AND MAJOR CARDIOVASCULAR EVENTS: ANALYSIS OF THE HOUSTON METHODIST CARDIOVASCULAR LEARNING HEALTH SYSTEM REGISTRY.
31. VARIATION OF CORONARY ATHEROSCLEROSIS ACROSS SPECTRUM OF INCREASING LP(A) USING QUANTITATIVE CCTA PLAQUE ANALYSIS: MIAMI HEART STUDY AT BAPTIST HEALTH SOUTH FLORIDA.
32. ASSOCIATION OF CARDIOVASCULAR RISK FACTORS TO QUANTITATIVE CORONARY PLAQUE CHARACTERISTICS: MIAMI HEART STUDY AT BAPTIST HEALTH SOUTH FLORIDA.
33. CORONARY ARTERY CALCIUM SCORE, SOCIAL VULNERABILITY AND INCIDENT CARDIOVASCULAR EVENTS.
34. RESIDENTIAL VERTICAL GREENSPACE AND SIDEWALKS IMPACTS ON CARDIOVASCULAR RISK: INSIGHTS FROM DEEP LEARNING-ENHANCED GOOGLE STREET VIEW.
35. DEEP LEARNING-BASED ASSESSMENT OF BUILT ENVIRONMENT AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS.
36. THE SOCIAL DETERMINANTS OF HEALTH AND TRENDS IN CARDIOVASCULAR MORTALITY IN PATIENTS WITH ATHEROSCLEROTIC PERIPHERALARTERIAL DISEASE IN THE UNITED STATES.
37. ASSOCIATION BETWEEN FINANCIAL TOXICITY AND ALL-CAUSE MORTALITY IN ADULTS WITH OBESITY.
38. IMPACT OF SOCIAL VULNERABILITY INDEX ON ADVERSE CARDIOVASCULAR DISEASE EVENTS AMONG PATIENTS WITH DIABETES MELLITUS: HOUSTON METHODIST CVD LEARNING HEALTH SYSTEM REGISTRY.
39. RELATIONSHIP BETWEEN DIFFERENTIAL QUANTITATIVE CORONARY PLAQUE AS ASSESSED ON CCTA ACROSS VARIOUS MEASURES OF OBESITY: MIAMI HEART STUDY AT BAPTIST HEALTH SOUTH FLORIDA.
40. CLINICAL AND SOCIODEMOGRAPHIC HETEROGENEITY FOR MORTALITY RISK BY OBESITY CLASS IN PATIENTS MEETINGELIGIBILITY CRITERIA FOR SEMAGLUTIDE CARDIOVASCULAR OUTCOME TRIALS: A NATIONAL POPULATION-BASED STUDY.
41. FINANCIAL TOXICITY AMONG INDIVIDUALS MEETING CRITERIA FOR SEMAGLUTIDE IN A US REPRESENTATIVE POPULATION WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.
42. IDENTIFYING PHENOTYPIC CLUSTERS AMONG ASCVD PATIENTS ELIGIBLE FOR SEMAGLUTIDE THERAPY IN A LARGE INTEGRATED HEALTHCARE SYSTEM.
43. BODY-MASS INDEX AND PER-CAPITA MEDICAL EXPENDITURES IN US ADULTS WITH ASCVD POTENTIALLY ELIGIBLE FOR SEMAGLUTIDE.
44. COST-RELATED MEDICATION NON-ADHERENCE IN SEMAGLUTIDE-ELIGIBLE US ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM US NATIONALLY REPRESENTATIVE POPULATION.
45. IMPACT OF CONTINUOUS GLUCOSE MONITORING ON GLYCEMIC CONTROL FOR PATIENTS WITH TYPE 2 DIABETES NOT ON INSULIN THERAPY WITH HIGH RISK FOR CARDIOVASCULAR DISEASE.
46. UNFAVORABLE SOCIAL DETERMINANTS OF HEALTH AND OBESITY: A DOUBLE JEOPARDY FOR PREMATURE MORTALITY.
47. QUANTIFYING LEAD-ATTRIBUTABLE CARDIOVASCULAR DISEASE BURDEN IN THE UNITED STATES.
48. IMPACT OF NON-TRADITIONAL CARDIOVASCULAR DISEASE RISK FACTORS ON ALZHEIMER'S DISEASE-RELATED DEMENTIAS.
49. SEMAGLUTIDE-ELIGIBILITY AMONG NATIONAL REPRESENTATIVE US ADULT POPULATION WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM NATIONAL HEALTH INTERVIEW SURVEY.
50. STRATIFIED PHENOTYPIC ANALYSIS AND MORTALITY OUTCOMES IN SEMAGLUTIDE-ELIGIBLE ASCVD PATIENTS: A NATIONAL HEALTH INTERVIEW SURVEY ANALYSIS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.